Ontologyof Drug Neuropathy Adverse Events
139 terms(s) returned
| Term Type: Class | Record: 1 to 50 of 139 Records | Page: 1 of 3, First Previous Next Last | Show Records Per Page |
- 14-alpha Demethylase Inhibitors [MoA]
- Acetyl Aldehyde Dehydrogenase Inhibitors [MoA]
- Active Transporter Interactions [MoA]
- Adrenergic Agonists [MoA]
- Adrenergic Antagonists [MoA]
- Adrenergic Receptor Interactions [MoA]
- Adrenergic alpha-Agonists [MoA]
- Adrenergic alpha-Antagonists [MoA]
- Adrenergic alpha2-Agonists [MoA]
- Adrenergic beta-Antagonists [MoA]
- Adrenergic beta1-Antagonists [MoA]
- Adrenergic beta2-Antagonists [MoA]
- Alkylating Activity [MoA]
- Androgen Receptor Antagonists [MoA]
- Angiotensin 2 Receptor Antagonists [MoA]
- Angiotensin-converting Enzyme Inhibitors [MoA]
- Antibody Interactions [MoA]
- Antibody-Receptor Interactions [MoA]
- Bcr-Abl Tyrosine Kinase Inhibitors [MoA]
- Binding Activity [MoA]
- Biological Response Modifiers [MoA]
- Bone Surface Interactions [MoA]
- Calcium Channel Antagonists [MoA]
- Calcium Channel Interactions [MoA]
- Cellular Structure Molecule Interactions [MoA]
- Chelating Activity [MoA]
- Chloride Channel Interactions [MoA]
- Cholesterol Synthesis Inhibitors [MoA]
- Cholinergic Agonists [MoA]
- Cholinergic Interactions [MoA]
- Cholinergic Muscarinic Agonists [MoA]
- Cholinergic Muscarinic Receptor Interactions [MoA]
- Cholinesterase Inhibitors [MoA]
- Corticosteroid Hormone Receptor Agonists [MoA]
- Cyclooxygenase 2 Inhibitors [MoA]
- Cyclooxygenase Inhibitors [MoA]
- Cytokine Receptor Superfamily Interactions [MoA]
- Dihydrofolate Reductase Inhibitors [MoA]
- Dopamine Agonists [MoA]
- Dopamine Antagonists [MoA]
- Dopamine Receptor Interactions [MoA]
- Dopamine Transporter Interactions [MoA]
- Dopamine Uptake Inhibitors [MoA]
- Enzyme Inhibitors [MoA]
- Estrogen Receptor Antagonists [MoA]
- Folic Acid Metabolism Inhibitors [MoA]
- G-Protein-linked Receptor Interactions [MoA]
- GABA A Modulators [MoA]
- GABA A Receptor Interactions [MoA]
- Glucocorticoid Receptor Agonists [MoA]
